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PCRA B S T R A C T
Objective: To determine the utility of polymerase chain reaction (PCR) for diagnosing pedi-
atric pulmonary tuberculosis (PPTB).
Method: A prospective cross-sectional study was carried out on 100 children less than
14 years of age, with strong clinical suspicion and radiological evidence suggestive of pul-
monary tuberculosis (TB). Sputum samples/gastric lavage were collected. Direct smears
and culture on Lowenstein Jensen (LJ) media were performed. DNA extraction and amplifi-
cation was performed using GeneiTM Amplification Reagent set forMycobacterium tuberculosis
(MTB) (by Genei, Bangalore, India). This test is based on the principle of single-tube nested
PCR which amplifies the repetitive insertion sequence IS6110.
Results: When compared with culture, sensitivity and specificity of PCR was 93.55% and
92.75%, respectively. The PPV was 85.29% and the NPV was 96.97%. When intention to treat
(ITT) was used as the standard, sensitivity, specificity, PPV and NPV of PCR was 47.88%,
93.1%, 94.4%, and 42.19%, respectively, and that of culture was 40.85%, 100%, 100% and
40.85%, respectively. Against response to treatment (RTT), PCR demonstrated sensitivity,
specificity, PPV and NPV of 50.9%, 93.1%, 93.33% and 50%, respectively, and for culture it
was 43.64%, 100%, 100% and 48.33%, respectively.
Conclusion/recommendation: The present study reinforces better case detection rate with
PCR-based nucleic acid amplification test as compared with microscopy and culture in
pediatric pulmonary TB. PCR showed a higher correlation with clinical diagnosis as com-
pared with microscopy and solid culture. Hence, a molecular platform should be the test
of choice for detecting PPTB.
 2015 Asian African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.ital, Parel,
gmail.com
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 4 ( 2 0 1 5 ) 4 8 –5 3 49Introduction
Pediatric pulmonary tuberculosis (PPTB) remains a major
cause of morbidity and mortality worldwide, particularly in
developing countries [1]. In India, it is estimated that 5–14%
of tuberculosis [TB] cases occur in children [2], and in Mum-
bai, the incidence was 9% in 2010 [3].
A major challenge to PPTB is establishing an accurate diag-
nosis. Children less than 5 years rarely expectorate sputum
for evaluation, and the disease is paucibacillary with a smear
positivity rate of <15% and a culture positivity rate of 30–40%
[4]. Gastric lavage and induced sputum only marginally
improve sensitivity [5]. Rapid culture systems with their
improved yield and reduced turnaround time still require a
period of 10 days in most cases and may not be cost effective
[6]. Most cases are diagnosed based on clinical presentations,
radiographic abnormalities, contact history and tuberculin
skin test results, all of which suffer from low specificity [7].
The development of polymerase chain reaction (PCR)-
based assays for the detection of mycobacterial DNA in clini-
cal specimens has proved to be a diagnostic boon. The role of
nucleic acid amplification tests (NAAT) has been well estab-
lishedworldwide [8]. Most NAATassays use themycobacterial
insertion element IS6110 as the target for detectingMycobacte-
rium tuberculosis (MTB) complex organisms. The reported sen-
sitivity in pediatric pulmonary specimens ranges from 95% to
100% in culture-positive cases and 50% to 60% in culture-neg-
ative cases [9]. For resource-constrained settings, the limita-
tions of NAATs include the expensive equipment, the high
cost per test and the need to obtain multiple specimens in
smear-negative patients to improve sensitivity. Hence, there
is an urgent need for a rapid, reliable and affordable diagnos-
tic test.
This study was carried out to determine the utility of a
PCR-based NAAT for diagnosing PPTB.
Materials and methods
Institutional ethics committee permission was obtained prior
to commencing the study. A prospective, cross-sectional study
was carried out on 100 children less than 14 years of age, with
strong clinical suspicion of pulmonary tuberculosis (PTB),
radiological evidence suggestive of PTB and whose parents/
guardians providedwritten informed consent. Symptoms that
were likely to suggest a diagnosis of PTB included: cough
P2 weeks’ duration and/or weight loss of at least 10% of
healthy body weight or no weight gain in 3 months and/or
fever for P2 weeks or one measured temperature above
38.5 C [10]. Children who were on anti-TB therapy (ATT) for
pulmonary/extra-pulmonary TB or those who had received
ATTwithin the last 6 months were excluded from the study.
From children older than 5 years of age and who could
expectorate, two sputum specimens (as per the Revised
National Tuberculosis Control Programme, RNTCP, protocol)
were collected in sterile, wide-mouthed, screw-capped con-
tainers [11]. In younger children and those who could not
expectorate, gastric lavage (GL) was collected by the
pediatrician on 3 consecutive days in sterile, wide-mouthed,screw-capped containers. The pH was immediately adjusted
to neutral with sodium bicarbonate [12].
Microbiology workup
All processing was carried out in Biological Safety Cabinet
(BSC) Type II, and level 2 biosafety practices were followed.
Microscopy
Direct smears were prepared from each of the specimens and
stained by Ziehl Neelsen method. The results were read and
recorded as per RNTCP protocol. Irrespective of the number
of sputum or GL specimens submitted per case, detection of
acid fast bacilli (AFB) in any one or all of the specimens sub-
mitted was considered as positive for that child.
Isolation and identification of MTB complex
All specimenswere decontaminatedwith N-acetyl-L-Cysteine
(NALC) NaOH method and concentrated by centrifuging at
3000g for 15 min [13]. Two loopsful of the sediment were inoc-
ulated on two Lowenstein Jensen (LJ) media. One was incu-
bated aerobically at 37 C and the other at room
temperature (25 C) [13]. All cultures were read daily for the
first week for detecting contamination or rapid growers and
then weekly thereafter for eight weeks or until growth was
detected, whichever was later. If mycobacterial growth was
detected in any one or all of the two/three specimens submit-
ted, it was considered as positive for that child. The isolates
were identified as MTBC using SD BIOLINE TB Ag MPT 64
Rapid immunochromatography assay after confirming their
acid-fast nature [14].
NAAT (PCR based)
DNA extraction and amplification was performed using Gen-
eiTM Amplification Reagent set for MTB (by Genei, Bangalore,
India) as per manufacturer’s instructions with minimal mod-
ifications [15]. The samples were decontaminated with NALC–
NaOH instead of using modified Petroff’s method, and the pel-
lets of all the specimens of a single patient were pooled so as
to get a single pellet on which NAATwas performed. 3 ll of a
DNA sample was added to 9 ll of the first amplification pre-
mix. This test is based on the principle of a single-tube-nested
PCR which amplifies the repetitive insertion sequence IS6110.
It is a two-step sequential assay. In the first step, the IS region
of the MTB complex DNA sequence, a 220 bp, is amplified by
specific external primers.
The external primer sequence was as follows:
695 to 724 (5 0-CGGGACCACCCGCGGCAAAGCCCGCAGGAC-
3 0) and
885 to 914 (50-CATCGTGGAAGCGACCCGCCAGCCCAGGAT-30)
The first amplification reaction profile consisted of a cycle
of an initial denaturation step at 22 C for 10 min and 94 C for
5 min, followed by 20 cycles at 94 C for 30 s (denaturation),
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and a final extension cycle of 70 C for 7 min. The vials were
removed from the thermal cycler when samples reached
4 C and then centrifuged at 10,000 rpm for 30 s before open-
ing to avoid aerosol contamination.
After the first PCR cycling was completed, 15 ll of the sec-
ond amplification master-mix was added to each tube and the
second NAATwas performed. The inner primers were used to
further amplify a 123 bp amplification product.
The inner primer sequence was as follows:
Primer IS1 [5 0-CCTGCGAGCGTAGGCGTCGG-3 0] and
Primer IS2 [5 0-CTCGTCCAGCGCCGCTTCGG-3 0]
The cycling parameters consisted of an initial cycle at
94 C for 5 min, followed by 30 cycles at 94 C for 30 s (denatur-
ation), 68 C for 30 s (annealing) and 72 C for 30 s (extension),
and a cycle of final extension at 72 C for 7 min. The kit also
includes an internal control DNA. The amplified products
were analyzed using gel electrophoresis. A band of 340 bp is
the amplification product of the internal control DNA. An
amplification product of size 123 bp is indicative of the pres-
ence of MTBC. Results were considered as positive if there
was a band both at 123 bp and 340 bp or a band only at
123 bp. The presence of only one band at 340 bp was consid-
ered negative. The DNA extraction was to be repeated if there
was no band at all as it indicated either that the sample con-
tained inhibitors or the DNA extraction had failed. Reprocess-
ing of such samples was to be carried out by repeating the
extraction procedure with 100 ll of the DNA.
Data recording
Clinical details, radiological findings and relevant laboratory
investigations, where available, and the treatment initiated
were recorded. Contact number of the patient’s caregiver
was also recorded for follow-up. Each child was followed up
and the response to treatment (RTT) was noted at the end
of 2 weeks for those receiving antibiotics only and at
6 months for those receiving anti-tuberculosis treatment
(ATT). A probable case, confirmed case, cured, treatment com-
pleted, death and treatment failure were defined as er RNTCP
guidelines [16].
Statistical analysis
100 clinically suspected PPTB cases were included. Data was
entered in the SPSS version 15.0. Performance of PCR-basedTable 1 – Comparison of Microscopy, culture and NAAT.






Negative 2 64NAAT was reported in terms of sensitivity and specificity at
95% confidence interval. Three reference standards were used
for comparison; intention to treat (ITT), response to ATT and
culture positivity.
Results (Table 1)
Of 100 consecutive, clinically suspected PPTB cases included
in the study, 36 were less than 5 years of age. Gender ratio
was observed to be equal. GL was obtained from 41 children
and expectorated sputum from 59 children.
Of the 241 specimens (123 GL and 118 sputa) tested by
microscopy and culture, and 100 pooled specimens from an
equal number of suspect children tested by PCR, PCR was
positive in 36 children, culture was positive in 31 and micros-
copy was positive in 13. In clinically suspected cases of PPTB,
the sensitivity of NAAT, culture and microscopy was 36%, 31%
and 13%, respectively. All the isolates were identified as MTBC
by ‘‘SD Bioline MPT 64 Rapid’’ test.
Concordant results by PCR-NAATand culture (Table 1) were
observed in 93 childrenwith 29 testing positive both by culture
and PCR and 64 testing negative by both. Discordance was
observed in 7 of which 5 were PCR-positive and culture-nega-
tive and 2were PCR-negative and culture-positive.When com-
pared with culture, sensitivity and specificity of PCR-NAAT
was 93.55% (95% CI: 78.54–99.02%) and 92.75% (95% CI: 83.88–
97.58%), respectively. The PPV was 85.29% (95% CI: 68.93–
94.99%) and NPV was 96.97% (95% CI: 89.46–99.54%).
Of the 100 children enrolled in the study, 29 received only
antibiotics (Amoxicillin or Cloxacillin and/or Amikacin) and
responded. Of these, none were acid-fast microscopy positive
or culture positive. However, 2 of thesewere NAAT positive. 71
children received ATT; NAATwas positive in 34 of these cases,
while culture was positive in 31 and microscopy in 13. When
ITTwas used as the standard, NAAT had a sensitivity, specific-
ity, PPV and NPV of 47.88% (95% CI: 35.88–60.08%), 93.1% (95%
CI: 77.19–98.95%), 94.4% (95% CI: 81.33–99.16%), and 42.19%
(95% CI: 29.94–55.18%). All that were positive by microscopy
were also positive by culture and PCR. The sensitivity, speci-
ficity, PPV and NPV of culture against ITT was 40.85% (95%
CI: 29.32–53.16%), 100% (95% CI: 87.94–100%), 100% (95% CI:
87.94–100%) and 40.85% (95% CI: 29.32–53.16%), respectively.
Of the 71 children initiated on ATT, 5 were lost to follow-up
and excluded from analysis. Of the remaining 66, treatment
completion was achieved in 55 (83.3%). Eleven children had
an adverse outcome of which 10 died during treatment and
1 was a treatment failure with culture-positive result. PCR
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to treatment, NAAT demonstrated a sensitivity, specificity,
PPV and NPV of 50.9% (95% CI: 37.07–64.64%), 93.1% (95% CI:
77.19–98.95%), 93.33% (95% CI: 77.89–98.99%) and 50% (95%
CI: 36.08–63.92%), respectively. Culture demonstrated a sensi-
tivity, specificity, PPV and NPV of 43.64% (95% CI: 30.31–
57.68%), 100% (95% CI: 87.94–100%), 100% (95% CI: 85.62–
100%) and 48.33% (95% CI: 35.23–61.6%), respectively.
Discussion
The conventional methods of diagnosis which include acid-
fast stained microscopy and culture perform poorly in PPTB.
In the present study on 100 children with clinical presentation
strongly suggestive of TB, performance of PCR-based NAAT
has been evaluated against culture on LJ medium, intention
to treat with ATT and RTT. This is one of the few studies
which included ITT and RTT as standards for defining perfor-
mance of the different diagnostic tests.
The results observed in the present study reinforce previ-
ous published data with reference to sensitivity, specificity
and rapidity of PCR-based assays [17–19]. In those 71 children
who received ATT, the sensitivity of PCR, culture and micros-
copy was 47.8%, 43.6% and 18.3%, respectively. Higher sensi-
tivities have been reported in literature [20–22]. However,
these have compared the performance of PCR against culture.
The higher sensitivity of any NAAT can be attributed to the
technology itself which amplifies the original load of DNA
more than a million times and in the present study, the use
of LJ medium instead of the recommended liquid culture sys-
tems (MGIT 960). PCR was positive in all 13 cases which were
smear-positive. In addition, PCR was also positive in 21 cases
which were smearnegative and 3 cases which were culture-
negative. In smear-negative cases, PCR is reported to have a
lower sensitivity as compared with liquid culture [23–25].
PCR was negative in two smear-negative but culture-posi-
tive cases. False negative NAAT may be due to the presence of
inhibitors not detected by the control amplification or non-
homogenous distribution of bacteria in the specimen so that
the fraction tested does not contain mycobacteria or a low
number of bacilli in the specimen. Both these reasons do
not apply to the present study. The following precautions
were taken to avoid false negative results. A recombinant
plasmid DNA was provided as an internal control during the
DNA extraction procedure to validate extraction protocol.
Absence of an internal control band at 340 bp indicated either
the presence of inhibitors or the failure of DNA extraction,
and the process of DNA extraction was to be repeated as
per manufacturer’s instructions. This was not observed in
any of the runs. All specimens were homogenized and con-
centrated before processing to improve the quality of speci-
men and to concentrate the bacillary load.
Five children were culture-negative and PCR-NAAT posi-
tive. Three of these were initiated on ATT and showed symp-
tomatic improvement. Hence, these were considered as cases
of TB. The remaining 2 children had a history of TB one year
prior. These children, however, responded to antibiotic treat-
ment and PCR may be false-positive. False-positive NAATs
can be due to multiple reasons. Carryover of amplicons fromprevious reactions is considered a major limitation of PCR-
based assays. To avoid false positivity arising from cross-con-
tamination, DNA extraction and NAATwere done in two sep-
arate laboratory areas away from the culture laboratory. PCR
workstation and dedicated equipment were used for reagent
preparation. Disposable plastic ware and filter-blocked tips
were used, and frequent changing of gloves was practiced.
Uracil DNA glycosylase (UDG) was added to the master mix
to minimize previous amplicon contamination and not more
than five samples were processed in a day. The other reason
for false positivity could be the amplification of DNA from
dead bacilli in the respiratory secretions following successful
ATT. Since DNA-based NAATs can also detect dead bacilli, the
results of NAAT should be used in conjunction with clinical
presentation and the pretest probabilities.
In the present study, culture positivity was 43.66% (31/71).
Studies from India have reported culture positivity ranging
from 32% to 37.7% [26–28]. A higher culture positivity has been
reported by Petrovi et al. (Serbia, 2005, 43%) [29] and Jeena
et al. (South Africa, 2002, 88%) [30]. Higher rates in these stud-
ies have been attributed to the use of a combination of
induced sputum and gastric lavage as specimens, as well as
the use of a combination of one solid and one liquid medium.
Though culture is highly specific for the diagnosis of TB, it is
relatively insensitive for pediatric TB when evaluated against
the clinical reference standard [31,32].
The comparatively lower yield with culture may be attrib-
uted to the use of only solid medium for culture. Liquid cul-
ture systems with continuous monitoring for mycobacterial
growth (such as MB/BacT) and mycobacterial growth indica-
tor tube (MGIT) provide a significantly higher yield than solid
culture and in half the time [6]. Microscopic observation drug
susceptibility (MODS) is a potentially low-cost alternative to
MGITwith comparable sensitivity [33].
In the present study, microscopy could detect only 18.3%
(13/71) of cases. The yield of acid-fast microscopy of respira-
tory samples in children has been found to be low, ranging
from 12% to 17.2% [26–28]. The inherent reasons for the low
sensitivity of microscopy in children has been attributed to
the paucibacillary nature of the disease and to the fact that
often the child lacks post-tussive expulsive force to bring
out a good quality sputum.
Excluding drop-outs and deaths, successful treatment out-
come was achieved in a total of 55 out of 66 children initiated
on ATT (83.3%). Though there is a wide margin for improving
treatment outcome, this would need an early diagnosis and
require the use of more accurate and rapid tests.
A mortality of 14.1% (10/71) was observed in the present
study. Oeltmann et al. reported 10.5% mortality (Botswana,
2008, 10.5%) [34], and Harries et al. reported 17% (Malawi,
2002) [35]. Death in young children can be attributed to the
rapid progression and dissemination of the disease.
Children usually acquire TB from adults. Thus, TB in chil-
dren reflects the ongoing transmission in the community and
indirectly reflects on the performance of national programs.
This emphasizes the need for early and accurate diagnosis
of the disease in children to benefit both the affected child
and the community. For a long time, RNTCP has emphasized
acid-fast microscopy for the diagnosis of PTB. The present
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microscopy and a better case detection rate with PCR-based
NAAT. Recent standards on TB care recommend that in all
children suspected of having pulmonary TB, microbiological
confirmation should be sought through examination of a
respiratory specimen for smear microscopy, Xpert MTB/RIF
assay and/or culture [36]. The GeneXpert MTB/RIF assay with
its simple procedure, rapid results, decreased turnaround
time and almost no expertise needed, is expectedly a better
option for detecting pediatric TB. The same is now recom-
mended by RNTCP [37].
This study has some limitations. The collection of speci-
mens were dependent on the pediatrician. Thus, there was
no control over the quality of the specimens and the transport
to the laboratory. Smear preparation after concentration of
the specimen and the use of fluorescent/LED microscopy
could have increased smear positivity. The use of liquid cul-
ture systems might have improved the culture yield.
All the three test modalities used in the present study
yielded sensitivity lower than that observed in adults. PCR-
NAAT showed a higher correlation with clinical diagnosis as
compared with microscopy and solid culture. Hence, a molec-
ular platform should be the test of choice for detecting PPTB.
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